I agree that this site is using cookies. You can find further informations
here
.
X
Login
My folder (
0
)
Home
About us
Home About us
Our history
Profile
Press & public relations
Friends
The library in figures
Exhibitions
Projects
Training, internships, careers
Films
Services & Information
Home Services & Information
Lending and interlibrary loans
Returns and renewals
Training and library tours
My Account
Library cards
New to the library?
Download Information
Opening hours
Learning spaces
PC, WLAN, copy, scan and print
Catalogs and collections
Home Catalogs and Collections
Rare books and manuscripts
Digital collections
Subject Areas
Our sites
Home Our sites
Central Library
Law Library (Juridicum)
BB Business and Economics (BB11)
BB Physics and Electrical Engineering
TB Engineering and Social Sciences
TB Economics and Nautical Sciences
TB Music
TB Art & Design
TB Bremerhaven
Contact the library
Home Contact the library
Staff Directory
Open access & publishing
Home Open access & publishing
Reference management: Citavi & RefWorks
Publishing documents
Open Access in Bremen
Show Desktop-Version
Toggle navigation
Anjidani, Nassim
31
results:
Search for persons
X
Format
Online (31)
Mediatypes
Articles (Online) (13)
OpenAccess-fulltext (18)
Sorted by: Relevance
Sorted by: Year
?
1
Comparative immunogenicity and safety of SpikoGen®, a recom..:
Tabarsi, Payam
;
Mamishi, Setareh
;
Anjidani, Nassim
...
International Immunopharmacology. 127 (2024) - p. 111436 , 2024
Link:
https://doi.org/10.1016/..
?
2
Efficacy and safety of the biosimilar denosumab candidate (..:
Jamshidi, Ahmadreza
;
Vojdanian, Mahdi
;
Soroush, Mohsen
...
Arthritis Research & Therapy. 24 (2022) 1 - p. , 2022
Link:
https://doi.org/10.1186/..
?
3
Immunogenicity and Safety of SpikoGen, an Adjuvanted Recomb..:
Nafar, Mohsen
;
Mostafaloo, Narges
;
Firouzan, Ahmad
...
Clinical Therapeutics. 44 (2022) 12 - p. 1566-1576 , 2022
Link:
https://doi.org/10.1016/..
?
4
Post-Marketing Surveillance of a generic Oxaliplatin (Alvox..:
Shahi, Farhad
;
Gorji, Mojtaba
;
Payandeh, Mehrdad
...
Current Therapeutic Research. 96 (2022) - p. 100657 , 2022
Link:
https://doi.org/10.1016/..
?
5
Immunogenicity and safety of SpikoGen®, an adjuvanted recom..:
Tabarsi, Payam
;
Anjidani, Nassim
;
Shahpari, Ramin
...
Immunology. 167 (2022) 3 - p. 340-353 , 2022
Link:
https://doi.org/10.1111/..
?
6
Evaluating the safety and effectiveness of PegaGen® (pegfil..:
Jenabian, Arash
;
Ehsanpour, Ali
;
Mortazavizadeh, Seyed Mohammad Reza
...
Supportive Care in Cancer. 30 (2022) 10 - p. 8151-8158 , 2022
Link:
https://doi.org/10.1007/..
?
7
A Post-Marketing Surveillance Study to Evaluate the Safety ..:
Shahi, Farhad
;
Vafaeezadeh, Farahnaz
;
Ansarinejad, Nafiseh
...
Current Therapeutic Research. 96 (2022) - p. 100659 , 2022
Link:
https://doi.org/10.1016/..
?
8
A Phase IV Study of the Safety and Efficacy of CinnoPar® i..:
Jamshidi, Ahmadreza
;
Gharibdoost, Farhad
;
Sedighi, Sima
...
Journal of Osteoporosis. 2021 (2021) - p. 1-6 , 2021
Link:
https://doi.org/10.1155/..
?
9
Pregnancy outcome in patients with multiple sclerosis treat..:
Seyed Ahadi, Maral
;
Sahraian, Mohammad Ali
;
Baghbanian, Seyed Mohammad
...
Multiple Sclerosis and Related Disorders. 47 (2021) - p. 102667 , 2021
Link:
https://doi.org/10.1016/..
?
10
Zytux in Refractory Myasthenia Gravis: A Multicenter, Open-..:
Fatehi, Farzad
;
Moradi, Kamyar
;
Okhovat, Ali Asghar
...
Frontiers in Neurology. 12 (2021) - p. , 2021
Link:
https://doi.org/10.3389/..
?
11
Assessment of Treatment Safety and Quality of Life in Patie..:
Gharibdoost, Farhad
;
Salari, Amir-Hossein
;
Salesi, Mansour
...
Advances in Therapy. 38 (2021) 2 - p. 1290-1300 , 2021
Link:
https://doi.org/10.1007/..
?
12
Efficacy and Safety of Proposed Bevacizumab Biosimilar BE10..:
Rezvani, Hamid
;
Mortazavizadeh, Seyed Mohammadreza
;
Allahyari, Abolghasem
...
Clinical Therapeutics. 42 (2020) 5 - p. 848-859 , 2020
Link:
https://doi.org/10.1016/..
?
13
Subcutaneous tocilizumab in adults with severe and critical..:
Malekzadeh, Reza
;
Abedini, Atefeh
;
Mohsenpour, Behzad
...
International Immunopharmacology. 89 (2020) - p. 107102 , 2020
Link:
https://doi.org/10.1016/..
?
14
Efficacy and safety of the biosimilar denosumab candidate (..:
Jamshidi, Ahmadreza
;
Vojdanian, Mahdi
;
Soroush, Mohsen
...
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC9245232/. , 2022
Link:
http://www.ncbi.nlm.nih...
?
15
Comparing efficacy and safety of P013, a proposed pertuzuma..:
Allahyari, Abolghasem
;
Ehsanpour, Ali
;
Ansarinejad, Nafiseh
...
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC9450379/. , 2022
Link:
http://www.ncbi.nlm.nih...
1-15